Position in BBIO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$97,070,889
-$24,751,674 QoQ
Shares Held
1,307,176
-17.9% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Mar 31, 2024CallValue
$1,020
CallShares
33
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. BBIO ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in BBIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,070,889 | 1,307,176 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $121,822,563 | 1,592,660 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $33,203,372 | 639,264 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,958,869 | 439,066 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,879,248 | 314,702 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $691,762 | 25,210 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $968,472 | 38,039 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $336,914 | 13,301 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,020 | 33 | Call | Defined | 2024-05-01 | |
| 2024-03-31 | $4,265,228 | 137,944 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $5,137,486 | 127,260 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,926,282 | 148,892 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,841,294 | 107,052 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,895,856 | 114,346 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,024,920 | 134,504 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $1,180,254 | 129,984 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,506,522 | 246,948 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $438,717 | 26,302 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,077,166 | 22,982 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $386,547 | 6,341 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $892,091 | 14,482 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $794,938 | 11,179 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $642,905 | 17,135 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $282,956 | 8,677 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $745,706 | 25,714 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||